Bharat Biotech says typhoid vaccine shown to be safe, effective in human trialsPost published:October 2, 2017Post category:Industry NewsClinical studies showed 87% effectiveness for Typbar-TCV typhoid vaccine, says Bharat Biotech Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMeet the Man Who Designed Your iPhone (It Wasn’t All Steve Jobs) Next PostD-Mart’s rising brand value shows that hyperlocal pays You Might Also Like Dilip Shanghvi’s oil firm may buy GSPC’s Hazira field August 9, 2017 Smart Motors and Drives with Integrated Sensors and Connectivity January 12, 2019 Could Barcelona Become the World’s Additive Manufacturing Hub? October 18, 2017